Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
In vitro Toxicology Market: By Technology, By Method, By Application, By End-user and Region Forecast 2019-2030
In vitro Toxicology Market: By Technology, By Method, By Application, By End-user and Region Forecast 2019-2030
In vitro Toxicology Market size was valued at US$ 11.2 billion in 2023 and is expected to grow US$ 21.2 billion by 2030 at a CAGR of 11.1% from 2024 to 2030. The global market report provides a detailed overview of the market, which has been segmented by technology, method, application, and end-user. The market has been segmented by technology into Cell Culture Technology, High Throughput Technology, Molecular Imaging, and OMICS Technology. The Cell Culture Technology segment is likely the largest and fastest growing in terms of technology. This method has segmented the market into Cellular Assay, Biochemical Assay, In Silico, and Ex-vivo.
The Cellular Assay segment will gain the maximum revenue share over the forecast period. The market has been segmented into Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, and Others. The Dermal Toxicity segment is expected to account for the high revenue share in 2022-2028. Based on end-user, the in-vitro toxicology is segmented into the Pharmaceutical Industry, Cosmetics and household Products, Diagnostics, Chemicals Industry, and Food Industry. According to Precision Business Insights, the Chemicals Industry segment is predicted to register the fastest growth rate during the forecast period.
Study Period
2024-2030Base Year
2023CAGR
11.1%Largest Market
North AmericaFastest Growing Market
Asia Pacific
An increase in the number of R&D activities that require in vitro testing, a restriction on animal testing, and increased awareness about environmental concerns are the factors driving the global in vitro toxicology testing market, which is likely to develop significantly throughout the forecast period.
The North American market is expected to witness the highest market share during the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 11.2 billion |
|
Market Size in 2030 |
US$ 21.2 billion |
|
Market CAGR |
11.1% |
|
By Technology |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
In vitro toxicology market size was valued at US$ 11.2 billion in 2023 and is set to reach US$ 21.2 billion by 2030 at a CAGR of 11.1% from 2019-2030
The major players in the global market are Agilent Technologies, Inc., Abbott, Beckman Coulter, Inc., Merck KGaA, Dassault Systèmes, GENERAL ELECTRIC COMPANY, Quest Diagnostics Incorporated, Labcorp Drug Development, Thermo Fisher Scientific Inc., Catalent, Inc., Charles River Laboratories International, Inc.
North America is the fastest-growing region for market
| 1. Executive Summary |
| 2. Global In vitro Toxicology Market Introduction |
| 2.1. Global In vitro Toxicology Market - Taxonomy |
| 2.2. Global In vitro Toxicology Market -Definitions |
| 2.2.1. By Technology |
| 2.2.2. By Method |
| 2.2.3. By Application |
| 3. Global In vitro Toxicology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global In vitro Toxicology Market Dynamic Factors - Impact Analysis |
| 4. Global In vitro Toxicology Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global In vitro Toxicology Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1. Cell Culture Technology |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. High Throughput Technology |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Molecular Imaging |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. OMICS Technology |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global In vitro Toxicology Market Forecast, By Method, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1. Cellular Assay |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Biochemical Assay |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. In Silico |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Ex-vivo |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global In vitro Toxicology Market Forecast, By Application, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1. Systemic Toxicology |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Dermal Toxicity |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Endocrine Disruption |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Ocular Toxicity |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global In vitro Toxicology Market Forecast, By End-user, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1. Pharmaceutical Industry |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Cosmetics & Household Products |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostics |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Chemicals Industry |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Food Industry |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Global In vitro Toxicology Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application, End-user and Region, 2024 - 2030 |
| 10. North America In-vitro ToxicologyMarketAnalysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Cell Culture Technology |
| 10.1.2. High Throughput Technology |
| 10.1.3. Molecular Imaging |
| 10.1.4. OMICS Technology |
| 10.2. Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Cellular Assay |
| 10.2.2. Biochemical Assay |
| 10.2.3. In Silico |
| 10.2.4. Ex-vivo |
| 10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Systemic Toxicology |
| 10.3.2. Dermal Toxicity |
| 10.3.3. Endocrine Disruption |
| 10.3.4. Ocular Toxicity |
| 10.3.5. Others |
| 10.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Pharmaceutical Industry |
| 10.4.2. Cosmetics & Household Products |
| 10.4.3. Diagnostics |
| 10.4.4. Chemicals Industry |
| 10.4.5. Food Industry |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2024 - 2030 |
| 10.7. North America In vitro Toxicology Market Dynamics - Trends |
| 11. Europe In vitro Toxicology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Cell Culture Technology |
| 11.1.2. High Throughput Technology |
| 11.1.3. Molecular Imaging |
| 11.1.4. OMICS Technology |
| 11.2. Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Cellular Assay |
| 11.2.2. Biochemical Assay |
| 11.2.3. In Silico |
| 11.2.4. Ex-vivo |
| 11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Systemic Toxicology |
| 11.3.2. Dermal Toxicity |
| 11.3.3. Endocrine Disruption |
| 11.3.4. Ocular Toxicity |
| 11.3.5. Others |
| 11.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Pharmaceutical Industry |
| 11.4.2. Cosmetics & Household Products |
| 11.4.3. Diagnostics |
| 11.4.4. Chemicals Industry |
| 11.4.5. Food Industry |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Poland |
| 11.5.8. Rest of Europe |
| 11.6. Europe In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2024 - 2030 |
| 11.7. Europe In vitro Toxicology Market Dynamics - Trends |
| 12. Asia-Pacific In vitro Toxicology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Cell Culture Technology |
| 12.1.2. High Throughput Technology |
| 12.1.3. Molecular Imaging |
| 12.1.4. OMICS Technology |
| 12.2. Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Cellular Assay |
| 12.2.2. Biochemical Assay |
| 12.2.3. In Silico |
| 12.2.4. Ex-vivo |
| 12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Systemic Toxicology |
| 12.3.2. Dermal Toxicity |
| 12.3.3. Endocrine Disruption |
| 12.3.4. Ocular Toxicity |
| 12.3.5. Others |
| 12.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Pharmaceutical Industry |
| 12.4.2. Cosmetics & Household Products |
| 12.4.3. Diagnostics |
| 12.4.4. Chemicals Industry |
| 12.4.5. Food Industry |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. Japan |
| 12.5.2. China |
| 12.5.3. India |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2024 - 2030 |
| 12.7. Asia-Pacific In vitro Toxicology Market Dynamics - Trends |
| 13. Latin America In vitro Toxicology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 13.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Cell Culture Technology |
| 13.1.2. High Throughput Technology |
| 13.1.3. Molecular Imaging |
| 13.1.4. OMICS Technology |
| 13.2. Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Cellular Assay |
| 13.2.2. Biochemical Assay |
| 13.2.3. In Silico |
| 13.2.4. Ex-vivo |
| 13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Systemic Toxicology |
| 13.3.2. Dermal Toxicity |
| 13.3.3. Endocrine Disruption |
| 13.3.4. Ocular Toxicity |
| 13.3.5. Others |
| 13.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Pharmaceutical Industry |
| 13.4.2. Cosmetics & Household Products |
| 13.4.3. Diagnostics |
| 13.4.4. Chemicals Industry |
| 13.4.5. Food Industry |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Argentina |
| 13.5.4. Rest of Latin America |
| 13.6. Latin America In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2024 - 2030 |
| 13.7. Latin America In vitro Toxicology Market Dynamics - Trends |
| 14. Middle East and Africa In vitro Toxicology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 14.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Cell Culture Technology |
| 14.1.2. High Throughput Technology |
| 14.1.3. Molecular Imaging |
| 14.1.4. OMICS Technology |
| 14.2. Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.2.1. Cellular Assay |
| 14.2.2. Biochemical Assay |
| 14.2.3. In Silico |
| 14.2.4. Ex-vivo |
| 14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Systemic Toxicology |
| 14.3.2. Dermal Toxicity |
| 14.3.3. Endocrine Disruption |
| 14.3.4. Ocular Toxicity |
| 14.3.5. Others |
| 14.4. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Pharmaceutical Industry |
| 14.4.2. Cosmetics & Household Products |
| 14.4.3. Diagnostics |
| 14.4.4. Chemicals Industry |
| 14.4.5. Food Industry |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. Israel |
| 14.5.3. South Africa |
| 14.5.4. Rest of MEA |
| 14.6. MEA In vitro Toxicology Market - Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2024 - 2030 |
| 14.7. MEA In vitro Toxicology Market Dynamics - Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Method& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Charles River |
| 15.2.2. Catalent, Inc. |
| 15.2.3. Eurofins Scientific |
| 15.2.4. Quest Diagnostics Incorporated |
| 15.2.5. Laboratory Corporation of America Holdings |
| 15.2.6. Evotec |
| 15.2.7. Creative Bioarray |
| 15.2.8. Gentronix |
| 15.2.9. HD Biosciences Co., Ltd. |
| 15.2.10. MB Research Laboratories |
| 15.2.11. BioIVT |
| 15.2.12. SGS SA |
| 15.2.13. GVK Biosciences Private Limited |
| 15.2.14. InSphero |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.